Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Prevention of Postoperative Delirium in Elderly T2D Patients Undergoing Cardiac Surgery
NCT06361238Phase 3Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in postoperative delirium (POD), sponsored by Nanjing Drum-Tower Hospital. Started Nov 2024; status: recruiting.
02
Drugs
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06361238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06361238.